Fact-checked by Grok 2 weeks ago

Multivitamin

A multivitamin, also known as a multivitamin/mineral (MVM) supplement, is a dietary product containing a combination of essential vitamins—typically including vitamins A, C, D, E, K, and the B-complex vitamins—often paired with minerals such as calcium, magnesium, zinc, and iron, intended to compensate for potential nutritional shortfalls in the diet. These supplements are formulated to approximate recommended daily allowances for adults or specific populations, though compositions vary widely across products, and they may include additional ingredients like herbs or amino acids in some cases. Available in forms such as tablets, capsules, gummies, liquids, and powders, multivitamins have been commercially available since the early 1940s, following advancements in vitamin isolation and synthesis during the early 20th century. Multivitamins are among the most commonly used dietary supplements and globally, with surveys indicating that about one-third of adults report regular consumption, often motivated by perceptions of bolstering immunity, , or overall . Proponents argue they address subclinical deficiencies in modern diets influenced by processed foods and factors, but first-principles evaluation of reveals that vitamins function as co-factors in metabolic pathways, where excess intake beyond tissue saturation yields diminishing or null returns absent deficiency. Empirical data from large studies, however, consistently show no extension of lifespan; a 2024 analysis of nearly 400,000 U.S. adults across three prospective cohorts found daily multivitamin use associated with a 4% higher all-cause mortality compared to non-users, after adjusting for confounders. Similarly, systematic reviews of randomized controlled trials (RCTs) demonstrate no reduction in or cancer incidence among generally healthy, well-nourished populations. Controversies surrounding multivitamins stem from discrepancies between observational associations—sometimes suggesting benefits—and causal evidence from RCTs, which often reveal neutral or adverse outcomes due to risks like oxidative stress from high-dose antioxidants or imbalances in mineral absorption. While meta-analyses of trials in older adults indicate modest improvements in global cognition and episodic memory, potentially attributable to correcting marginal deficiencies in vulnerable groups, these effects are small and do not generalize to younger or deficient-specific contexts without targeted testing. Overall, causal realism underscores that multivitamins cannot substitute for dietary patterns rich in whole foods, where nutrient bioavailability and synergies exceed isolated supplementation, and routine use in nutrient-replete individuals lacks substantiation beyond placebo.

Composition and Formulations

Core Components and Dosages

Multivitamin formulations typically encompass the 13 essential vitamins required for human health: , , , , , thiamin (B1), riboflavin (B2), niacin (B3), pantothenic acid (B5), , biotin (B7), folate (B9), and vitamin B12. These are included to address potential gaps in dietary intake of micronutrients critical for metabolic functions, immune support, and cellular maintenance. Common minerals in multivitamins include calcium, , magnesium, iron, , , , , , , iodine, and sometimes or , selected based on prevalence of deficiencies or challenges in food sources. Iron is often higher or exclusive in formulations targeted at premenopausal women due to menstrual blood loss, while calcium and magnesium levels are constrained by formulation size. Standard once-daily adult multivitamins aim to deliver amounts approximating 100% of the U.S. Food and Drug Administration's (FDA) Daily Values (), which serve as reference intakes for labeling and are derived from recommended dietary allowances adjusted for population averages. Dosages typically range from 50% to 150% for most vitamins to balance efficacy and safety margins, avoiding upper tolerable intake levels that could risk for fat-soluble vitamins like A and D. Mineral dosages are lower for space-intensive elements; for instance, calcium rarely exceeds 20-30% per tablet due to its bulk. The following table outlines the FDA DVs for key vitamins and minerals commonly targeted in adult multivitamin compositions:
NutrientDaily Value (Adult)
900 mcg RAE
90 mg
20 mcg
15 mg
120 mcg
Thiamin (B1)1.2 mg
(B2)1.3 mg
(B3)16 mg NE
1.7 mg
400 mcg DFE
2.4 mcg
30 mcg
5 mg
Calcium1,300 mg
Iron18 mg
Magnesium420 mg
11 mg
55 mcg
0.9 mg
2.3 mg
35 mcg
45 mcg
Iodine150 mcg
Actual amounts vary by product, population (e.g., higher in senior formulas), and regulatory standards, with independent analyses showing label claims often met within 10-20% for vitamins but greater variability for minerals due to factors. Consumers should verify labels against current DVs, as formulations evolve with updated nutritional guidelines, such as the 2016 revision increasing and E DVs.

Specialized Variants

Specialized multivitamins deviate from standard adult formulations by adjusting nutrient profiles to align with physiological demands of particular life stages, genders, or conditions, such as reduced iron in senior formulas to mitigate overload risks or elevated folic acid in prenatal versions to support fetal development. These adaptations stem from observed differences in , , and requirements; for instance, older adults often exhibit diminished B12 uptake due to , necessitating higher doses in targeted products. However, while compositional tailoring reflects empirical variances—like pregnancy-induced declines in vitamins A, C, D, and —broad remains contingent on individual deficiencies rather than universal benefit. Prenatal multivitamins typically include 400–800 mcg of folic acid to reduce risks, alongside 27–30 mg iron for expanded , 1,000–1,300 mg calcium for skeletal formation, and 600 IU for maternal bone health and fetal growth, reflecting recommendations from bodies like the American College of Obstetricians and Gynecologists. supports folic acid's causal role in preventing up to 70% of defects when taken periconceptionally, though other components like omega-3s show inconsistent benefits for prevention. Formulations vary, with some incorporating choline (450 mg daily recommended) for neurodevelopment, but label discrepancies in nutrient amounts—up to 20–50% deviations—underscore issues in over-the-counter products. Multivitamins for seniors (often labeled 50+ or 55+) prioritize higher (800–2,000 ) and B12 (25–100 mcg) to counter age-related deficiencies linked to and cognitive decline, while omitting or minimizing iron (0–8 mg) to avoid hemochromatosis risks in men and postmenopausal women. inefficiencies, such as 30–50% reduced B12 in those over 60, justify these elevations, with randomized trials indicating multivitamin use may slow cognitive aging by 1–2 years equivalent in tasks. Calcium (1,200 mg) and magnesium are amplified for , though evidence for fracture prevention is mixed without concurrent exercise. Children's formulations deliver 50–100% of age-adjusted RDAs, with lower overall doses (e.g., 400–600 vitamin D vs. 1,000 adult) to prevent , often in chewable or gummy forms for , and emphasize iron (7–10 mg for ages 4–8) if diets lack sources. Unlike adults, these rarely exceed needs for fat-soluble vitamins A, D, E, K to avert risks, as pediatric requirements scale with body mass and growth rates; however, most healthy children derive sufficient nutrients from varied diets, rendering supplements unnecessary absent clinical deficiencies. Gender-specific variants adjust for sex-based differences: women's include higher iron (18 mg) and folic acid (400 mcg) for menstrual losses and reproductive health, while men's feature elevated (11–15 mg) for testosterone support and function, with reduced iron to match lower losses. A 2023 meta-analysis of trials found multivitamin benefits—such as 10–15% incidence reduction—primarily in men, potentially due to higher baseline or dietary gaps, though overall evidence questions the necessity of sex-tailored formulas over ones meeting RDAs.

Historical Development

Pre-20th Century Origins

Ancient civilizations empirically addressed conditions later identified as vitamin deficiencies through dietary interventions rich in specific nutrients. In , circa 1550 BCE, the prescribed the application of juice from roasted or fried ox liver to the eyes for treating , or night blindness, a practice also noted among Babylonians, , and Arabs; the liver's high content provided the curative factor, though unrecognized at the time. Similarly, (c. 460–370 BCE), often regarded as the father of medicine, emphasized tailored nutritional regimens using foods like , , and to restore health and prevent disease, laying foundational principles for diet-based remedies without isolating individual components. By the , systematic experimentation advanced these practices. Scottish naval surgeon conducted a controlled trial in 1747 aboard HMS Salisbury, dividing 12 -afflicted sailors into groups receiving different treatments; those given citrus fruits, such as , recovered rapidly, demonstrating the efficacy of vitamin C-rich sources against the disease, as detailed in his 1753 Treatise on Scurvy. Concurrently, emerged as a folk remedy in northern European communities for and general debility, with Manchester physician Thomas Percival documenting its benefits in the late 18th century; the oil supplied vitamins A and D, essential for bone health and immune function, predating formal identification of these factors. In the , amid industrialization and dietary shifts, such remedies persisted alongside emerging chemical analyses of foods, though true multivitamin formulations awaited 20th-century biochemistry. Physicians prescribed routinely for by the , while tonics incorporating iron, , or animal extracts targeted and fatigue, reflecting an intuitive grasp of multifaceted nutritional needs without scientific validation of micronutrients. These pre-modern approaches, grounded in observation rather than , highlighted the therapeutic value of nutrient-dense foods and oils, foreshadowing the recognition that multiple factors—later termed vitamins—were required for preventing deficiency diseases.

Modern Commercialization and Standardization

Commercial multivitamin products first appeared in the United States in the early 1940s, coinciding with advances in vitamin synthesis and isolation that enabled the formulation of combined supplements providing multiple essential nutrients in a single preparation. These early offerings targeted perceived dietary gaps in the general population, with marketing emphasizing preventive health benefits amid growing awareness of micronutrient deficiencies observed during World War II rationing and military nutrition studies. By 1943, innovations like the first "one-a-day" multivitamin streamlined consumer use by delivering Recommended Dietary Allowances (RDAs) in a daily dose, facilitating broader adoption. Postwar economic expansion accelerated commercialization, with pharmaceutical companies such as (later ) and scaling production and distribution through pharmacies, grocery stores, and direct mail. Sales grew rapidly; by the , multivitamins were staples in household medicine cabinets, promoted via print advertisements and recommendations for vitality and immunity support, though empirical evidence for universal benefits remained limited to deficiency correction. The market evolved to include variants for specific demographics, such as prenatal formulas, reflecting consumer demand but also prompting regulatory scrutiny over . Standardization initiatives paralleled this growth to ensure product consistency and safety. The (USP) formed a Vitamin Advisory Board in 1932, developing biological assay methods and reference standards for vitamins A and D as early benchmarks for potency and purity. In 1941, the (FDA) issued regulations mandating accurate labeling of vitamin content against established minimum daily requirements, prohibiting misleading potency claims and laying groundwork for RDAs formalized in subsequent decades. Further refinements occurred amid debates over regulatory scope. The 1976 Vitamins and Minerals Amendments (Proxmire Amendments) curtailed FDA authority to restrict supplement potencies exceeding RDAs, preserving high-dose formulations favored by manufacturers while prioritizing consumer access over pre-market efficacy reviews. The 1994 Health and Education Act (DSHEA) classified multivitamins as foods rather than drugs, shifting primary responsibility for safety and labeling to producers under Good Manufacturing Practices (GMPs), with standards remaining voluntary but influential for quality verification. These measures standardized identity and disclosure but left variability in and quality, as evidenced by ongoing voluntary testing revealing inconsistencies in some products.

Intended Applications

Preventive Health Maintenance

Multivitamin supplementation is commonly employed for preventive , aiming to offset potential dietary shortfalls in micronutrients and thereby mitigate risks of chronic conditions such as , (CVD), and cognitive decline in otherwise healthy individuals. Large randomized controlled trials and meta-analyses, however, demonstrate limited efficacy for broad preventive effects in well-nourished populations. For instance, the Physicians' Health Study II (PHS II), involving over 14,000 male physicians followed for a of 11.2 years, reported a modest 8% reduction in total cancer incidence with daily multivitamin use compared to , though no significant impact on CVD events or overall mortality was observed. This finding suggests a potential targeted benefit for in older men, but it has not been consistently replicated across sexes or broader demographics. Regarding cardiovascular outcomes and all-cause mortality, evidence consistently shows no preventive advantage. A 2022 U.S. Preventive Services systematic review of 84 randomized clinical trials found and supplements, including multivitamins, associated with little or no reduction in CVD incidence, cancer, or death among adults without known deficiencies. Similarly, a 2024 analysis of three large U.S. cohorts encompassing nearly 400,000 healthy adults revealed that regular multivitamin use correlated with a 4% higher all-cause mortality over follow-up periods exceeding 20 years in some subgroups, with no mortality benefit overall. Meta-analyses reinforce this, indicating neutral effects on CVD mortality ( 1.00). Emerging data highlight modest cognitive benefits as a potential preventive domain, particularly in aging populations. The trial, a randomized of over 21,000 U.S. adults aged 60 and older, demonstrated that daily multivitamin-mineral supplementation improved global and , equivalent to slowing cognitive aging by approximately 1.8 years over three years, based on of ancillary cognitive substudies. These effects were attributed to addressing subtle gaps affecting , though long-term impacts on prevention remain unestablished. Overall, while multivitamins may offer marginal insurance against subclinical deficiencies, they do not substantiate claims of comprehensive preventive health maintenance, with benefits confined to specific endpoints and populations rather than general or avoidance.

Supplementation for At-Risk Groups

Multiple supplementation, including multivitamins, has demonstrated benefits for pregnant women in reducing risks of adverse birth outcomes. A 2020 meta-analysis of randomized controlled trials found that multiple supplements during lowered rates of , small-for-gestational-age infants, and low birthweight compared to iron-folic acid alone. Similarly, a Cochrane review of trials involving over 100,000 women indicated that such supplementation resulted in fewer low birthweight babies (less than 2500 grams) and reduced maternal . These effects are attributed to addressing common deficiencies in vitamins A, D, and , as well as minerals like , which support fetal growth and in populations with suboptimal diets. In older adults, who often face reduced nutrient absorption, polypharmacy interactions, and dietary inadequacies, multivitamin use shows evidence of cognitive preservation. The COSMOS-Mind trial, a randomized placebo-controlled study of over 2,200 participants aged 65 and older, reported that daily multivitamin supplementation improved immediate recall memory after one year and slowed global cognitive decline equivalent to two years of aging over three years. A 2023 NIH-funded analysis of this trial confirmed modest memory enhancements, suggesting multivitamins may mitigate subclinical deficiencies in B vitamins and antioxidants that contribute to neurodegeneration. However, these benefits appear limited to memory domains and do not extend to preventing cardiovascular events or overall mortality in this group. For malnourished children, particularly in low-resource settings, multivitamin supplementation aids growth recovery and nutritional status. A 2025 systematic review of trials in normal and children found that multivitamins significantly increased , height velocity, and appetite in deficient subgroups, enhancing biochemical markers of recovery. In severe acute malnutrition protocols, adjunctive mixes improved weight-for-height z-scores and neurodevelopmental outcomes when combined with standard therapy. Such interventions are recommended by CDC guidelines for refugees or children with clinical evidence of poor , targeting deficiencies in vitamins A, C, and D that exacerbate stunting and immune impairment. Individuals with chronic conditions involving , such as post-bariatric surgery patients or those with , may benefit from multivitamins to prevent deficiencies, though large-scale meta-analyses show inconsistent outcomes for broader disease progression. For instance, in hemodialysis patients, routine multivitamin use lacks strong evidence for improving survival or cardiovascular risks, per a emphasizing targeted single-nutrient therapy over broad supplementation. In contrast, for metabolic dysfunction-associated steatotic , preliminary 2025 data suggest multivitamins may reduce markers, but causal links to histological improvements remain unestablished. Overall, efficacy in these groups hinges on documented deficiencies rather than universal application, with NIH guidance prioritizing assessment of intake and biomarkers before supplementation.

Evidence of Benefits

Efficacy in Nutrient-Deficient Contexts

In populations with established nutrient deficiencies, such as children in low- and middle-income countries (LMICs), multiple (MMN) supplementation—often delivered via powders or multivitamin/ formulations—has demonstrated efficacy in reducing and . A WHO review of randomized trials found that MMN powders, when added to complementary foods for children aged 2–12 years, significantly lowered the risk of , with effects most pronounced in settings of high baseline prevalence. Similarly, meta-analyses of trials in deficient pediatric cohorts show MMN interventions outperforming single- or dual-nutrient supplements in improving concentrations, serum and levels, and overall reduction. Linear growth and developmental outcomes also benefit from MMN in malnutrition-prone contexts. Systematic reviews of interventions in LMICs indicate that regular MMN provision from ages 3–24 months increases height-for-age z-scores, with compliant children gaining approximately 0.2–0.4 cm more length than controls, addressing stunting linked to multiple deficiencies like and . In broader child health assessments, MMN supplementation enhances , motor development, and morbidity reduction where gaps are widespread, though effects vary by compliance and baseline status. For pregnant women in nutrient-poor environments, MMN exceeds iron-folic acid alone in efficacy. An individual patient data meta-analysis of 17 randomized trials involving over 112,000 women in LMICs reported a 10% relative reduction in low birth weight and small-for-gestational-age infants with daily MMN, alongside lower preterm birth risks, attributable to corrected deficiencies in vitamins A, B, C, D, and minerals like iodine and zinc.30371-6/fulltext) These outcomes align with component-specific evidence, such as vitamin A supplementation yielding 12–24% all-cause mortality reductions in deficient children under five, underscoring multivitamin contributions in poly-deficient scenarios. While MMN addresses multiple gaps efficiently, efficacy depends on formulation matching local deficiencies (e.g., higher iron or in anemia-endemic areas) and sustained adherence, with randomized trials confirming no excess adverse events in these groups. Targeted single-nutrient therapy may outperform broad-spectrum MMN for isolated deficiencies, but in comorbid , comprehensive supplementation yields superior holistic improvements.

Outcomes in General Populations

Large-scale randomized controlled trials (RCTs) and meta-analyses evaluating multivitamin supplementation in generally healthy, nutrient-replete adults have yielded mixed but predominantly null results for major outcomes, with few consistent benefits observed beyond specific subgroups or endpoints. In populations without diagnosed deficiencies, such as middle-aged and older adults from with access to fortified foods and balanced diets, multivitamins do not appear to substantially alter incidence or when assessed over years to decades. Regarding all-cause mortality, a 2024 analysis of three prospective U.S. cohorts involving 390,124 healthy adults followed for over 20 years found no association between daily multivitamin use and reduced risk of death from any cause, including after adjusting for factors like quality and exercise. Similarly, a 2022 and network of RCTs concluded that and supplements, including multivitamins, provided little or no benefit in preventing death in primary prevention settings among non-deficient individuals. A 2018 of clinical trials and cohorts further confirmed no impact on cardiovascular mortality. For cancer outcomes, the Physicians' Health Study II (PHS II), a 2012 RCT of 14,641 male U.S. physicians aged 50 and older without prior cancer, reported a modest 8% relative reduction in total cancer incidence (excluding non-melanoma ) after 11.2 years of daily Centrum Silver multivitamin use versus ( 0.92, 95% CI 0.86-0.998). The trial, a 2022-2024 RCT of 21,442 U.S. adults aged 60 and older, similarly observed an 8% reduction in total invasive cancer risk with daily multivitamin-mineral supplementation, though this did not reach the prespecified statistical threshold for the primary endpoint. However, neither trial demonstrated reductions in cancer mortality, and observational data have not consistently replicated these incidence findings. Cardiovascular disease (CVD) endpoints show no benefits in general populations. PHS II found no reduction in major CVD events, , , or CVD mortality after over a of follow-up ( for major events 1.01, 95% CI 0.92-1.10). A 2018 meta-analysis of 16 RCTs and 9 cohorts involving over 2 million participants corroborated that multivitamin-multimineral supplementation does not improve CVD outcomes, including events or mortality. Emerging evidence suggests modest cognitive benefits in older adults. Substudies from , published in 2024, analyzed 5,000+ participants aged 60+ and found that daily multivitamin-mineral use improved global and over 3 years, equivalent to slowing age-related decline by approximately 2 years compared to (standardized mean difference 0.07 for global ). This aligns with two prior RCTs but contrasts with a 2013 RCT of 5,947 men aged 65+ showing no cognitive slowing. Meta-analyses within reinforce benefits for executive function and memory but emphasize small effect sizes unlikely to translate to clinically meaningful prevention in nutrient-sufficient groups. Overall, while isolated trials indicate potential for minor reductions in cancer risk or cognitive slowing, the absence of effects on mortality, CVD, or broad morbidity underscores limited utility of multivitamins for primary prevention in well-nourished general populations, consistent with guidelines prioritizing dietary sources over supplements.

Evidence of Risks and Limitations

Acute and Chronic Adverse Effects

Acute adverse effects from multivitamins primarily occur in cases of overdose, such as accidental by children or excessive self-administration of high-potency formulations. Symptoms often include , , , , and blurry vision, particularly associated with excess ; iron-containing multivitamins pose a higher risk, potentially causing severe gastrointestinal hemorrhage or organ damage in pediatric overdoses. Water-soluble vitamins like B6 can lead to acute neuropathy or sensory issues at supratherapeutic doses, though such events are rare with standard products. Chronic adverse effects are uncommon with recommended doses of multivitamins, which typically stay below established upper intake levels for most nutrients, but prolonged excessive consumption—especially of fat-soluble vitamins—can result in . For , chronic intake exceeding 3,000 mcg retinol activity equivalents daily may cause , desquamating , liver , and intracranial ; evidence links this primarily to supplements rather than . overload from sustained high dosing (e.g., >4,000 daily) induces hypercalcemia, manifesting as fatigue, , kidney stones, and vascular calcification. Iron and accumulation in multivitamins has been hypothesized to contribute to and risks like or , though direct causal evidence from multivitamin trials remains limited. Large-scale randomized trials and systematic reviews of multivitamin use in healthy adults report no consistent serious chronic harms, with minor issues like gastrointestinal discomfort or occurring at low rates comparable to groups. Risks are elevated in vulnerable populations, such as those with impaired renal function or concurrent high dietary intake, underscoring the need for individualized assessment over blanket supplementation.

Null or Negative Findings from Large-Scale Studies

The Physicians' Health Study II, a randomized, double-blind, placebo-controlled involving 14,641 U.S. physicians aged 50 years or older followed for a of 11.2 years, found that daily multivitamin supplementation (Centrum Silver) did not reduce the of major cardiovascular events, including , , or cardiovascular mortality, with hazard ratios close to 1.0 across endpoints. This null result persisted despite the study's power to detect clinically meaningful reductions and adjustment for confounders like age, , and . Similarly, the COcoa Supplement and Multivitamin Outcomes Study (), a of 21,442 U.S. adults aged 60 or older followed for 3.6 years, reported no significant reduction in total cardiovascular events from daily multivitamin use (also Centrum Silver), with a of 0.93 (95% , 0.85-1.02) that did not meet for primary CVD outcomes. Meta-analyses of randomized controlled trials reinforce these findings. A 2018 systematic review and of 21 trials involving over 91,000 participants concluded that multivitamin-multimineral supplementation conferred no benefit for prevention, with pooled risk ratios of 1.02 for CVD events and 0.98 for all-cause mortality, indicating null effects in generally healthy, nutrient-replete populations. Another 2013 of 91,000 participants across 21 randomized trials found no significant impact on all-cause mortality (RR 1.04, 95% CI 0.98-1.10), though it noted a non-significant trend toward slight harm, consistent with prior observational data suggesting potential risks in certain subgroups. Prospective cohort studies further highlight the absence of longevity benefits. Analysis of three large U.S. cohorts (, Health Professionals Follow-up Study, and Physicians' Health Study I) totaling 390,124 healthy adults with over 5.9 million person-years of follow-up through 2023 showed that daily multivitamin use was not associated with reduced all-cause mortality (adjusted HR 1.02, 95% CI 1.00-1.03 after multivariable adjustment), with initial crude analyses even suggesting a 4% higher risk that attenuated but did not reverse to benefit. These results align with U.S. Preventive Services Task Force recommendations against routine multivitamin use for primary prevention in adults, citing insufficient evidence for mortality or risk reduction in developed countries with adequate intake. Overall, large-scale evidence indicates that multivitamins do not extend lifespan or prevent major cardiovascular outcomes in well-nourished populations, potentially reflecting baseline sufficiency that limits supplementation's causal impact.

Regulatory Landscape

United States Framework

In the , multivitamins are classified as under the Dietary Supplement Health and Education Act of 1994 (DSHEA), which amended the Federal Food, Drug, and Cosmetic Act to treat them as a subset of foods rather than drugs. This framework exempts from pre-market approval by the (FDA) for safety or efficacy, shifting primary responsibility to manufacturers to ensure products are not adulterated or misbranded before entering the market. For ingredients in multivitamins that qualify as new dietary ingredients—those not present in the food supply as of October 15, 1994—a manufacturer must submit a 75-day pre-market notification to the demonstrating reasonable expectation of safety based on . However, most vitamins and minerals in standard multivitamins are established dietary ingredients exempt from this requirement. Labeling for multivitamins must include a "Supplement Facts" panel detailing serving size, amounts, and percent Daily Values where applicable, along with a full list of ingredients and manufacturer contact information for reporting. Permitted claims are limited to content statements (e.g., "contains 100% DV of ") or / claims (e.g., "calcium builds strong bones"), which require manufacturer substantiation as truthful and non-misleading, advance notification to the FDA, and inclusion of a stating the FDA has not evaluated the claim. Disease treatment, prevention, or cure claims are prohibited, as they would reclassify the product as an unapproved drug subject to stricter drug regulations. The () oversees advertising, requiring claims to be backed by competent and reliable . Manufacturing facilities producing multivitamins must comply with current good manufacturing practices (cGMPs) outlined in 21 CFR Part 111, which mandate quality control procedures, record-keeping, and testing to prevent contamination and ensure identity, purity, strength, and composition. FDA conducts post-market inspections and can issue warning letters, seize products, or initiate recalls if violations are found, such as contamination or unsubstantiated claims. Facilities must also register with the FDA under the Bioterrorism Act of 2002, though this applies broadly to food facilities including supplement producers. As of 2025, the core DSHEA framework remains unchanged for multivitamins, though the FDA's Unified Regulatory Agenda includes proposed rules on dietary ingredient notifications and front-of-package labeling that could indirectly affect supplement oversight.

Global Variations and Standards

Internationally, the Codex Alimentarius Commission, jointly administered by the (FAO) and (WHO), provides non-binding guidelines for vitamin and mineral food supplements through CXG 55-2005, adopted in 2005, which emphasizes safe upper levels, labeling consistent with Codex Stan 1-1985, and composition based on nutritional needs without specifying mandatory maximum doses. These guidelines aim to facilitate and harmonize standards but lack enforcement power, leading to diverse national implementations influenced by local dietary patterns and risk assessments. In the , multivitamins fall under food supplement regulations per Directive 2002/46/EC, which harmonizes permitted vitamins and minerals (e.g., 13 vitamins and 15 minerals listed in Annexes I and II) but delegates maximum levels to subsequent legislation like Regulation (EC) No 1925/2006, where tolerable upper intake levels (ULs) derived from scientific risk assessments cap dosages for select such as at 3,000 μg RE/day for adults. The (EFSA) conducts safety evaluations, yet member states retain authority for notification or registration, resulting in variations like Germany's stricter pre-market approval for novel sources versus France's focus on substantiation. Claims must be authorized under Regulation (EC) No 1924/2006, limiting assertions to established functions without implying disease treatment. Asia exhibits pronounced regulatory divergence; Japan's Ministry of Health, Labour and Welfare classifies multivitamins under Foods for Specified Health Uses (FOSHU) or Foods with Function Claims, requiring scientific evidence for efficacy claims and upper limits aligned with Japanese dietary reference intakes, such as 100 mg/day for in standard formulations. In , the mandates registration for "health foods" including multivitamins, with dosage caps (e.g., 2,000 IU/day for ) and mandatory clinical trials for novel claims, reflecting a pharmaceutical-like oversight stricter than food categories. ASEAN countries, per harmonized guidelines updated in 2024, set maximum levels for vitamins and minerals in health supplements (e.g., 600 mg/day for ), but implementation varies, with aligning limits to regional peers while prohibiting certain high-potency imports. In , multivitamins are regulated as natural health products under the Natural Health Products Regulations (2004), necessitating product licenses with evidence of safety and quality, including monograph-based allowances for standard doses (e.g., up to 1,000 mg/day for ) but site licenses for manufacturers to ensure GMP compliance. and , via the and TGA-equivalent, treat them as complementary medicines requiring pre-market assessment, with listed ingredients limited to those in approved compendia and potency caps like 45 mg/day for iron to mitigate overdose risks. These frameworks prioritize risk-based upper limits over the more permissive U.S. model, often citing EFSA or national toxicology data, though enforcement gaps persist in developing regions where informal markets dominate without standardized testing.

Controversies and Critical Perspectives

Marketing Hype Versus Empirical Data

Marketing claims for multivitamins frequently portray them as essential for overall enhancement, prevention, and in well-nourished individuals, often leveraging appeals to "" ingredients and broad promises of immune support, energy boosts, and . The industry, including multivitamins, drives substantial consumer spending—projected at $35.6 billion annually in the U.S. by 2022—fueled by advertising that emphasizes unsubstantiated panacea-like benefits despite regulatory scrutiny from bodies like the , which has pursued over 120 cases against false claims for supplements. These promotions persist even as evidence indicates limited beyond addressing specific deficiencies, with often outpacing rigorous validation. In contrast, large-scale randomized controlled trials (RCTs) reveal modest or null effects on major health outcomes in general populations. The Physicians' Health Study II, involving 14,641 male U.S. physicians followed for over a decade, found daily multivitamin use reduced total cancer incidence by 8% but yielded no significant reductions in cardiovascular events, , , or overall mortality. Similarly, the COSMOS trial, a 3.6-year RCT with 21,442 older U.S. adults, reported an 8% lower risk of total cancer with multivitamin-mineral supplementation but no impact on events or mortality, though subgroup analyses suggested minor cognitive benefits equivalent to slowing aging by about 1.8 years. Meta-analyses of primary prevention trials further underscore the disconnect, showing multivitamin use confers little to no benefit for preventing cancer, , or death in healthy adults. A 2024 analysis of nearly 400,000 U.S. adults across three cohorts, with over 20 years of follow-up, found no association between daily multivitamin use and reduced all-cause mortality, with hazard ratios near 1.0 for total, cancer, and CVD deaths. Another of RCTs reported no effect on vascular or cancer mortality (relative risks of 1.01 and 0.96, respectively), aligning with U.S. Preventive Services conclusions that does not support routine supplementation for broad preventive in non-deficient populations. These findings highlight that while multivitamins may fill nutrient gaps in deficient contexts, expansive marketing narratives exceed the empirical support from high-quality, long-term data. Empirical models of nutrient intake often depict a U-shaped curve, where health outcomes optimize within narrow physiological ranges, with deficiencies or excesses from supplements potentially yielding neutral or adverse effects rather than universal gains promoted in advertising. This underscores causal realism: multivitamins do not substitute for dietary patterns providing balanced, bioavailable nutrients, and over-reliance may foster complacency toward evidence-based nutrition. Industry-funded studies occasionally amplify minor subgroup benefits, but independent syntheses prioritize null results from adequately powered trials, revealing hype as largely unsubstantiated for primary prevention in affluent, nourished demographics.

Influence of Industry and Policy Debates

The Dietary Supplement Health and Education Act (DSHEA) of 1994, which exempted dietary supplements including multivitamins from pre-market FDA approval requirements unlike pharmaceuticals, resulted from intensive lobbying by the supplement industry against proposed FDA restrictions on vitamins and minerals sales. Industry groups, supported by figures like Senator Orrin Hatch, argued for consumer access and positioned supplements as distinct from drugs not intended to treat diseases, framing tighter regulation as overreach that could stifle innovation. This legislation shifted the burden to the FDA to prove adulteration post-market, a process critics contend enables unverified products to proliferate amid limited enforcement resources. Ongoing policy debates center on reforming DSHEA to mandate pre-market safety data or enhanced adverse event reporting, with supplement trade associations like the Council for Responsible Nutrition (CRN) opposing such changes to preserve market freedom and expand access via health savings accounts. Proponents of stricter oversight, including the , highlight underregulation allowing 50,000–80,000 products with unknown risks, citing instances of contamination and . Industry responses emphasize self-regulation and voluntary compliance, as seen in efforts to defend DSHEA's 30-year framework against calls for drug-like scrutiny. Industry funding influences research debates, with meta-epidemiologic analyses indicating biased effect sizes favoring positive outcomes in supplement studies sponsored by manufacturers, potentially skewing policy toward leniency. For multivitamins specifically, pharmaceutical firms like , which markets Centrum, have faced pressure to retract health claims after trials like the Physicians' Health Study II showed null benefits, illustrating tensions between supplement marketing and empirical demands for . Broader conflicts arise from pharmaceutical opposition to high-dose vitamin policies, such as resistance to elevated guidelines, prioritizing patented drugs over commoditized nutrients. These dynamics underscore how economic incentives from a $50 billion supplement sector shape regulatory inertia, often prioritizing industry growth over rigorous safety validation.

References

  1. [1]
    Multivitamin/mineral Supplements - Health Professional Fact Sheet
    Jul 17, 2024 · Another team defined MVMs as full-spectrum products providing all 12 vitamins plus 10 minerals [9]. Some published reports of studies of dietary ...Introduction · Extent of Multivitamin/mineral... · Multivitamin/minerals and Health
  2. [2]
    Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts
    Jun 26, 2024 · This cohort study examines the association of multivitamin use with mortality risk in 3 large, geographically diverse cohorts of generally ...
  3. [3]
    Vitamin and Mineral Supplements for the Primary Prevention of ...
    Jun 21, 2022 · This systematic review was conducted to provide current evidence on the benefits and harms of vitamin and mineral supplementation in healthy ...
  4. [4]
    Effect of multivitamin-mineral supplementation versus placebo on ...
    Jan 18, 2024 · The meta-analysis within COSMOS cognitive substudies indicates that daily MVM significantly benefits both global cognition and episodic memory.Abstract · Statistical Analyses · Discussion
  5. [5]
    Vitamin and Mineral Supplements: Do We Really Need Them? - PMC
    The results of large-scale randomized trials show that, for the majority of the population, there is no overall benefit from taking MVM supplements.
  6. [6]
    Vitamins: MedlinePlus Medical Encyclopedia
    Jan 21, 2025 · Vitamins are a group of substances that are needed for normal cell function, growth, and development. There are 13 essential vitamins.Pantothenic acid and biotin · Vitamin B12 · Vitamin B6 · ThiaminMissing: typical core<|separator|>
  7. [7]
    Analytical ingredient content and variability of adult multivitamin ...
    Regression results are reported for 8 vitamins (folic acid, niacin, riboflavin, thiamin, vitamin B-12, vitamin B-6, vitamin C, and vitamin E) and 10 minerals.Missing: core | Show results with:core
  8. [8]
    Daily Value on the Nutrition and Supplement Facts Labels - FDA
    Mar 5, 2024 · Vitamin A, 900mcg RAE. Vitamin B6, 1.7mg. Vitamin B12, 2.4mcg. Vitamin C, 90mg. Vitamin D, 20mcg. Vitamin E, 15mg alpha-tocopherol. Vitamin K ...Missing: core | Show results with:core
  9. [9]
    Multivitamin/mineral supplements: Rationale and safety
    Basic formulations are for broad-spectrum use. Formulations for special populations such as children, pregnant women, and seniors provide the same vitamins ...
  10. [10]
    Vitamins and Minerals for Older Adults | National Institute on Aging
    Jan 2, 2021 · Older adults may have different vitamin and mineral needs than younger adults. Find recommended amounts and information on calcium, sodium, ...
  11. [11]
    Evidence based recommendations for an optimal prenatal ...
    Jul 11, 2022 · The blood levels of most vitamins decrease during pregnancy if un-supplemented, including vitamins A, C, D, K, B1, B3, B5, B6, folate, ...
  12. [12]
    Evidence-Based Recommendations for an Optimal Prenatal ...
    Therefore, for U.S. women we recommend that prenatal supplements contain approximately 1.3 mg of copper, based on the limited research to date. Supplementation ...
  13. [13]
    Prenatal vitamins: Why they matter, how to choose - Mayo Clinic
    It also might be beneficial to look for a prenatal vitamin that contains vitamin C, vitamin A, vitamin E, B vitamins, zinc and iodine. In addition, your ...Missing: evidence | Show results with:evidence
  14. [14]
    Evidence based recommendations for an optimal prenatal ...
    The blood levels of most vitamins decrease during pregnancy if un-supplemented, including vitamins A, C, D, K, B1, B3, B5, B6, folate, biotin, and B12.
  15. [15]
    Selecting a dietary supplement with appropriate dosing for 6 key ...
    We estimated the usual intake of vitamins A and D, folate, calcium, iron, and ω-3 FAs from foods alone. We calculated the target doses of supplementation needed ...
  16. [16]
    [PDF] GAO-24-106689, Prenatal Supplements: Amounts of Some Key ...
    Dec 12, 2023 · Almost all (11 of 12) tested prenatal supplements had at least one tested nutrient that differed from the label amounts.Missing: composition | Show results with:composition
  17. [17]
    What to Know About Multivitamins for Seniors - WebMD
    Feb 26, 2024 · Senior multivitamins are designed to fill gaps in your diet by supplementing vitamins and minerals your body needs to thrive.
  18. [18]
    Third Major Study Finds Evidence that Daily Multivitamin ...
    Jan 18, 2024 · Third Major Study Finds Evidence that Daily Multivitamin Supplements Improve Memory and Slow Cognitive Aging in Older Adults. In a meta- ...
  19. [19]
    5 health-boosting supplements for older adults | UnitedHealthcare
    5 health-boosting supplements for older adults · 1. Calcium · 2. Vitamin D · 3. Fish oil (omega- 3s) · 4. Vitamin B12 · 5. Magnesium.1. Calcium · 2. Vitamin D · 3. Fish Oil (omega- 3s)
  20. [20]
    [PDF] Comparison of Adult and Children's MVM Products - USDA ARS
    Many adult MVM products had much higher levels of many of the vitamins and some of the minerals than in the children's MVM products.
  21. [21]
    Vitamins for Kids: Do Children Really Need Supplements?
    Nov 9, 2022 · Adult vitamins have dosages that aren't appropriate for kids. ... A good children's multivitamin should contain calcium, vitamin D and iron, says ...
  22. [22]
    Multivitamins: Do young children need them? - Mayo Clinic
    Most healthy children don't need multivitamins if they are growing at the typical rate and eating a variety of foods.
  23. [23]
    Do Kids Need Vitamin Supplements? | Johns Hopkins Medicine
    Typically kids don't need vitamins, but every kid is different and has different needs, so consult your pediatrician if you are worried.<|separator|>
  24. [24]
    Men's vs. Women's Multivitamins: What's the Difference? | vitafusion™
    For example, men need more zinc than women while women generally need more iron than men. While men and women can have different nutrient requirements, people ...
  25. [25]
    Difference between men, women and child multi vitamins - Brant Arts
    Adult vs. Children's Multi Vitamins. Children's multi vitamins are far more likely to be in chewable form since it can be difficult for kids to swallow pills.
  26. [26]
    the effect of sex in multivitamin-multimineral-based cancer prevention
    Aug 10, 2023 · Sex could influence the effect of MVM supplementation in reducing cancer incidence, with supplementation being effective only in male individuals.
  27. [27]
    Do Men and Women Need Separate Multivitamins? - Well
    Dec 9, 2016 · It makes sense to get one tailored to your age and gender, though many experts question whether you need to take a multivitamin at all.
  28. [28]
    Night blindness and ancient remedy - PubMed
    The old Egyptians, the Babylonians, the Greeks and the Arabs used animal liver for treatment and successfully cured the disease. The author had the opportunity ...
  29. [29]
    The Nineveh Medical Project - Liver as a cure for blindness - Oracc
    Ancient Egyptians used ox liver as a remedy. It was roasted and/or smoked and its fluid was sprayed into the eyes of the sufferer.
  30. [30]
    “Let food be thy medicine...” - PMC - PubMed Central - NIH
    Mark Lucock ends his review of the science of folic acid by quoting Hippocrates: “Let food be thy medicine and medicine be thy food” (p 211).
  31. [31]
    Health care practices in ancient Greece: The Hippocratic ideal - NIH
    He believed that in order to properly and quickly heal the wounds they must be kept dry, after being taken care of using pure water or wine (20). In addition, ...
  32. [32]
    Lind and scurvy: 1747 to 1795 - PMC - NIH
    Lind's Treatise of the Scurvy 1 is a good illustration of the basis for mid-18th century judgement and decision-making in at least two respects.
  33. [33]
    Lind J (1753) - The James Lind Library
    In 1747, James Lind, a Scottish naval surgeon faced with uncertainty about which of many proposed treatments for scurvy to use, compared six of them in a ...
  34. [34]
    The Man with a Fish on His Back | Science History Institute
    Apr 3, 2010 · Northern European fishing communities used cod-liver oil for generations to restore health and alleviate aches and pains before the doctors and ...
  35. [35]
    “English Disease”: Historical Notes on Rickets, the Bone–Lung Link ...
    Cod liver oil was often proposed as one of the therapies and Thomas Percival in Manchester in the 18th century was the first reporting its medical use [64].
  36. [36]
    Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective
    In this article, the history of rickets pertaining to the discovery of vitamin D, cod-liver oil, and sunlight is reviewed.
  37. [37]
    Vitamin D: part II; cod liver oil, ultraviolet radiation, and eradication of ...
    Jan 9, 2019 · Occasional papers before 1900 pointed to its efficacy for rickets, and most textbooks of the early 1900s mentioned it only as a treatment option ...
  38. [38]
    Introduction and Background - Dietary Supplements - NCBI Bookshelf
    In 1973 FDA issued regulations that prohibited certain representations on vitamin and mineral supplement labels, established standards of identity for vitamin ...
  39. [39]
    The History of Vitamins | Timeline - Supplement Factory
    Sep 19, 2024 · In 1943, the first one-a-day multivitamin was introduced. By the 1950s, multivitamins had become widely available and were commonly promoted ...
  40. [40]
    Early Vitamin and Supplement Companies - Health Food History
    Signature product: Multi-vitamin/mineral concentrates; one of the first commercial multivitamins in America. 1935 – Seven Seas (Hull, U.K.) Founders ...
  41. [41]
    History of vitamin and supplement advertising: Proof that nothing is ...
    Apr 25, 2022 · Vitamin companies have been advertising the questionable benefits of supplements for a century without much oversight to how they do it.
  42. [42]
    USP and Dietary Supplements ... A Return to Our Roots
    Sep 11, 2014 · USP established a Vitamin Advisory Board in 1932 and the very first USP reference standards distributed were Vitamins A & D in Cod Liver Oil.
  43. [43]
    The FDA, Vitamins, and the Dietary Supplement Industry
    Oct 17, 2008 · The FDA established regulations in 1941 to govern labeling of vitamins, establishing a Minimum Daily Requirement for each vitamin, but the ...<|control11|><|separator|>
  44. [44]
    Milestones in US Food and Drug Law - FDA
    Jan 30, 2023 · Vitamins and Minerals Amendments ("Proxmire Amendments") stop FDA from establishing standards limiting potency of vitamins and minerals in food ...
  45. [45]
    Building trust for over 200 years: A timeline of USP
    In 1994, federal legislation recognized USP as official standards for dietary supplements. Products that don't meet USP standards, but whose suppliers claim ...
  46. [46]
    The history of efforts to regulate dietary supplements in the USA
    Nov 23, 2015 · This review examines the emergence of dietary supplements and how the Food and Drug Administration (FDA) attempted to regulate these.<|separator|>
  47. [47]
    the Physicians' Health Study II randomized controlled trial - PubMed
    Nov 14, 2012 · In this large prevention trial of male physicians, daily multivitamin supplementation modestly but significantly reduced the risk of total cancer.
  48. [48]
    Vitamin and Mineral Supplements for the Primary Prevention of ...
    Jun 21, 2022 · Vitamin and mineral supplementation was associated with little or no benefit in preventing cancer, cardiovascular disease, and death.
  49. [49]
    Multivitamin-multimineral supplementation and mortality - PubMed
    Conclusion: Multivitamin-multimineral treatment has no effect on mortality risk. Publication types. Meta-Analysis; Research Support, Non-U.S. Gov't; Review ...
  50. [50]
    Effect of multivitamin-mineral supplementation versus placebo on ...
    Jan 18, 2024 · The meta-analysis within COSMOS cognitive substudies indicates that daily MVM significantly benefits both global cognition and episodic memory.
  51. [51]
    Effects of cocoa extract and a multivitamin on cognitive function
    Sep 14, 2022 · Daily multivitamin-mineral (MVM) supplementation for 3 years improved global cognition, episodic memory, and executive function in older adults.
  52. [52]
    Vitamin and Mineral Supplementation During Pregnancy on ...
    Feb 14, 2020 · Meta-analyses showed improvement in several key birth outcomes, such as preterm birth, small-for-gestational age (SGA) and low birthweight with MMN ...
  53. [53]
    Vitamin and mineral supplements for women during pregnancy
    Mar 15, 2019 · We found that pregnant women who received multiple-micronutrient supplementation had fewer babies that were born too small (weighing less than 2500 g),
  54. [54]
    Review article Maternal folic acid and multivitamin supplementation
    A positive impact from MMN supplementation during pregnancy for iron and folic acid is supported for several birth outcomes (decreased maternal anemia at term; ...
  55. [55]
    Multivitamin Supplementation Improves Memory in Older Adults
    May 24, 2023 · Conclusions: Daily multivitamin supplementation, compared with placebo, improves memory in older adults. Multivitamin supplementation holds ...
  56. [56]
    Multivitamin-Mineral Supplement Slows Age-Related Cognitive ...
    Mar 7, 2024 · The researchers estimate that the daily multivitamin slowed global cognitive aging by the equivalent of two years compared to placebo..
  57. [57]
    Daily multivitamin may enhance memory in older adults - NIH
    Jun 13, 2023 · A large clinical trial found that daily multivitamins led to modest improvements in memory over a three-year period in older adults.
  58. [58]
    The therapeutic effects of multivitamins on growth in normal and ...
    Aug 8, 2025 · Objectives: To evaluate the effect of multivitamin and MMN supplementation on child growth outcomes, including height standard deviation score ( ...
  59. [59]
    [PDF] The therapeutic effects of multivitamins on growth in normal and ...
    Jul 3, 2025 · In malnourished children, multivitamins have been shown to enhance nutritional recovery by improving weight gain, appetite, and biochemical ...
  60. [60]
    Nutrition and Growth | Immigrant and Refugee Health - CDC
    May 20, 2025 · Refugees with clinical or laboratory evidence of poor nutrition may benefit from a multivitamin or individual vitamin supplementation according ...Background · Table 3. Micronutrient... · Nutrition Evaluation During...
  61. [61]
    Is Routine Multivitamin Supplementation Necessary in US Chronic ...
    Multivitamin supplements are commonly provided to HD patients in the United States. We systematically reviewed the literature and found no strong evidence for ...
  62. [62]
    Multivitamin supplementation and its impact in metabolic dysfunction ...
    Mar 13, 2025 · Multivitamins, widely consumed dietary supplements, have been proposed to modulate oxidative stress and inflammation, potentially impacting MASLD progression.
  63. [63]
    Multiple micronutrient powders for point-of-use fortification of foods ...
    Aug 9, 2023 · Multiple micronutrient powders have been shown to reduce the risk of iron deficiency and anaemia in children aged 2–12 years of age.
  64. [64]
    Provision of Multiple Rather Than Two or Fewer Micronutrients More ...
    Multiple micronutrients (MMN) improve child growth, weight, hemoglobin, zinc, retinol, motor development, and reduce anemia, compared to 1-2 micronutrients.
  65. [65]
    Multiple micronutrient supplementation during early childhood ...
    Conclusions: MM supplements increased the length of children who consumed them regularly from 3 to 24 mo. Strategies that promote compliance through effective ...
  66. [66]
    Do Multiple Micronutrient Interventions Improve Child Health ...
    MMN interventions may result in improved outcomes for children in settings where micronutrient deficiencies are widespread.
  67. [67]
    Vitamin A Deficiency in Children - UNICEF DATA
    Aug 25, 2025 · Periodic, high-dose vitamin A supplementation is a proven, low-cost intervention [1] which has been shown to reduce all-cause mortality by 12 to ...
  68. [68]
    Addressing nutritional gaps with multivitamin and mineral supplements
    In bridging nutrient gaps, it is plausible that MVMs help prevent iron-deficiency anemia, neural tube defects, neurological damage in people age 50 years and ...
  69. [69]
    Micronutrient Supplementation and Fortification Interventions on ...
    This review systematically synthesizes the available evidence on the strategies used to prevent micronutrient malnutrition among children under-five in LMICs.
  70. [70]
    Health effects of vitamin and mineral supplements - The BMJ
    Jun 29, 2020 · Another systematic review reported a reduced risk of stroke in association with supplementation of homocysteine lowering B vitamins,22 but ...Are Supplements Needed? · Population Nutrient... · What Next?<|separator|>
  71. [71]
    Association of Multivitamin and Mineral Supplementation and Risk ...
    Jul 10, 2018 · In conclusion, our comprehensive meta-analysis demonstrates that MVM supplement use does not improve cardiovascular outcomes. Our study supports ...<|separator|>
  72. [72]
    COSMOS Trial – COcoa Supplement and Multivitamin Outcomes ...
    We found a modest but significant 8% reduction in total cancer,9 and no effect on cardiovascular disease.10 Further, there was suggestive evidence that daily ...Study Findings · Q & A · Publications · Ancillary StudiesMissing: population | Show results with:population
  73. [73]
    Multivitamins in the Prevention of Cardiovascular Disease in Men
    Nov 7, 2012 · Taking a daily multivitamin did not reduce major cardiovascular events, MI, stroke, and CVD mortality after more than a decade of treatment and follow-up.
  74. [74]
    A Randomized Trial of Long-term Multivitamin Supplementation and ...
    In this large, randomized, placebo controlled trial among 5,947 men aged 65 and over, we observed no benefit of a daily multivitamin in slowing cognitive ...
  75. [75]
    Multiple vitamin overdose: MedlinePlus Medical Encyclopedia
    Jul 1, 2023 · Vitamin A overdose can cause nausea and vomiting, dizziness, blurry vision. Additional symptoms of a multivitamin overdose in different parts of ...
  76. [76]
    Too much of a good thing? Toxic effects of vitamin and mineral ... - NIH
    The agents: For otherwise healthy individuals, daily consumption of a multivitamin is often recommended to round out a well-balanced diet. ... toxicity warnings ...
  77. [77]
    Vitamin B6 Toxicity - StatPearls - NCBI Bookshelf
    Almost all cases of vitamin B6 toxicity are from supratherapeutic dosing, either iatrogenic or laypersons self-treating with over-the-counter supplements.
  78. [78]
    Vitamin A Toxicity - StatPearls - NCBI Bookshelf
    Sep 2, 2023 · However, poison control centers receive thousands of calls yearly related to vitamin overdoses and potential toxicity. An interprofessional team ...
  79. [79]
    The safety of commonly used vitamins and minerals - PubMed Central
    Aug 2, 2021 · Supplements can cause potential harms such as adverse reactions, drug interactions, monetary cost, delay of more effective therapy, false hope, and increased ...
  80. [80]
    Vitamin D Toxicity - StatPearls - NCBI Bookshelf
    May 24, 2023 · Toxicity of vitamin D leads to hypercalcemia and an imbalance in the regulation of bone metabolism; the resultant hypercalcemia leads to clinical ...
  81. [81]
    Dangerous Side Effects and Risks of 8 Popular Supplements
    Jul 11, 2025 · Iron and copper in multivitamins can contribute to iron or copper overload, and increase the risk of dementia, diabetes, and cardiovascular ...Missing: acute adverse
  82. [82]
    The Efficacy and Safety of Multivitamin and Mineral Supplement Use ...
    Sep 5, 2006 · The potential adverse effects of multivitamin and mineral supplements have not been systematically determined in well-designed randomized, ...
  83. [83]
    Multivitamins in the prevention of cardiovascular disease in men
    Nov 7, 2012 · Taking a daily multivitamin did not reduce major cardiovascular events, MI, stroke, and CVD mortality after more than a decade of treatment and follow-up.
  84. [84]
    the COcoa Supplement and Multivitamin Outcomes Study (COSMOS ...
    Jun 7, 2022 · Cocoa extract supplementation did not significantly reduce total cardiovascular events among older adults but reduced CVD death by 27%.
  85. [85]
    A meta-analysis of randomized controlled trials - ResearchGate
    Aug 7, 2025 · Recent epidemiologic findings suggest that multivitamin use increases the risk of mortality. Objective: We aimed to determine whether ...
  86. [86]
    Daily multivitamins to reduce mortality, cardiovascular disease ... - NIH
    Bottom line. Current evidence does not support the routine use of multivitamins to reduce mortality, CVD, or cancer for people in developed countries.
  87. [87]
    Dietary Supplements - FDA
    Oct 1, 2024 · Under the Dietary Supplement Health and Education Act of 1994 (DSHEA):. Manufacturers and distributors of dietary supplements and dietary ...Information for Consumers · Information on Select Dietary... · Information for Industry
  88. [88]
    Questions and Answers on Dietary Supplements - FDA
    Feb 21, 2024 · The Dietary Supplement Health and Education Act (DSHEA) requires that a manufacturer or distributor notify FDA in advance and submit safety ...
  89. [89]
    [PDF] GUIDELINES FOR VITAMIN AND MINERAL FOOD SUPPLEMENTS ...
    5.1 Vitamin and mineral food supplements should be labelled according to the Codex Standard for the Labelling of Prepackaged Foods (Codex-Stan 1-1985, Rev. 1- ...
  90. [90]
    Responses to Questions about Codex and Dietary Supplements | FDA
    Mar 21, 2018 · In July of 2005, the Codex Alimentarius Commission adopted the Guidelines for Vitamin and Mineral Food Supplements.What is Codex? · What work has Codex... · Why won't these Guidelines...
  91. [91]
    Food supplements - European Commission's Food Safety
    Directive 2002/46/EC on food supplements envisages the setting of maximum and minimum amounts of vitamins and minerals in supplements.About food supplements · Levels of vitamins and... · Use of substances
  92. [92]
    Food supplements - EFSA - European Union
    The reference EU legislation in the area of food supplements is Directive 2002/46/EC, which establishes harmonised lists of the vitamins and minerals substances ...<|separator|>
  93. [93]
    Supplement Regulations in the European Union: An Overview
    Mar 15, 2021 · An essential guide to supplement regulations in the EU, including Directive 2002/46/EC, General Food Law, Novel Food Regulation, and more.Food Supplements: Directive... · Other EU Food Regulations
  94. [94]
    [PDF] Comparing Dietary Supplement Regulations in the U.S. and Abroad
    Jan 1, 2021 · This Article analyzes the regulation of dietary supplements in the United States and around the world. The purpose of this Article is to ...
  95. [95]
    ASEAN: Big Changes on Vitamin and Mineral Limits for Health ...
    Sep 6, 2024 · The current maximum limits for vitamins and minerals in Vietnam are not matched to those in neighboring countries or to those in the ASEAN ...
  96. [96]
    A Global Overview of Dietary Supplements: Regulation, Market ...
    The legislative texts under Directive 1925/2006/EC allow for the prohibition or exclusion of certain ingredients, other than vitamins and minerals, to be added ...
  97. [97]
    International Regulations on Dietary Supplements: Challenges and ...
    Sep 26, 2024 · This article explains how dietary supplements are regulated differently worldwide, with a focus on challenges and opportunities in various countries.
  98. [98]
    A natural deception: 3 marketing myths the supplement industry ...
    Apr 5, 2024 · The appeal to nature fallacy occurs when you assume that because something is “natural” it must be good.Missing: multivitamin | Show results with:multivitamin
  99. [99]
    Vitamin Panacea: Is Advertising Fueling Demand for Products with ...
    This study examines the effect of advertising on demand for vitamins—products with spiraling sales despite little evidence of efficacy.
  100. [100]
    Don't waste time (or money) on dietary supplements - Harvard Health
    Apr 1, 2022 · In 2022, Americans are projected to spend $35.6 billion on dietary supplements, even though there is little, if any, evidence of benefits.
  101. [101]
    Health Claims | Federal Trade Commission
    The FTC has filed one hundred and twenty cases challenging health claims made for supplements. Meanwhile, in recent years there has been a trend in food ...
  102. [102]
    The Truth About Supplements: Separating Science from Marketing ...
    Despite their popularity, the evidence for multivitamins improving health outcomes in well-nourished populations is surprisingly weak. Large-scale studies ...Missing: empirical | Show results with:empirical
  103. [103]
    Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts - PMC
    Jun 26, 2024 · These findings suggest that multivitamin use to improve longevity is not supported. This cohort study examines the association of multivitamin ...
  104. [104]
    a meta-analysis of randomized controlled trials - ScienceDirect.com
    Recent epidemiologic findings suggest that multivitamin use increases the risk of mortality. ... By performing a meta-analysis of RCTs, the current study ...Multivitamin-Multimineral... · Subjects And Methods · Discussion
  105. [105]
    The Truth About Vitamins: What Nutritional Supplement Research ...
    Jul 29, 2025 · Multiple reviews have found that multivitamin/mineral supplementation shows minimal effect on cardiovascular disease risk, cancer incidence, or ...Missing: empirical | Show results with:empirical
  106. [106]
    Harvard epidemiologist aims to sort fact from fiction on dietary ...
    Mar 21, 2018 · A Harvard epidemiologist is working on two trials aimed at providing some clarity on the effects of dietary supplements.
  107. [107]
    Recent Developments in Multivitamin/Mineral Research
    The definition, “dietary supplements containing 3 or more vitamins,” is basic and broad (18). Although this definition allows for the inclusion of more products ...
  108. [108]
    How Sen. Orrin Hatch Changed America's Health Care
    Jan 2, 2019 · Some legislators and consumer advocacy groups wanted vitamins and other supplements to go through a tight approval process, akin to the testing ...
  109. [109]
    Greg Horn's business of nutrition: DSHEA turns 30
    May 28, 2024 · In 1993, the supplement industry lobbied against FDA's regulations to restrict the sale of the VMS category. The industry launched the “Save ...<|separator|>
  110. [110]
    Dietary supplements, drugs and DSHEA - Orrin G. Hatch Foundation
    Jul 23, 2025 · Dietary supplements, unlike drugs, are not intended to treat disease and are regulated by DSHEA, which has a drug exclusion clause. DSHEA ...
  111. [111]
    Dietary Supplements and Public Safety: A Defense of DSHEA's ...
    Jun 20, 2019 · Consumer groundswell and grassroots lobbying of Congress leading to the passage of DSHEA helped the growth of the industry as much as did the ...
  112. [112]
    Too Little, Too Late: Ineffective Regulation of Dietary Supplements in ...
    FDA authority is limited in regulating supplements sold before October 1994. Supplements may theoretically be marketed at any concentration, as long as the ...
  113. [113]
    Legislation/Advocacy | Council for Responsible Nutrition
    Fully implement and enforce the Dietary Supplement Health and Education Act (DSHEA) of 1994, the amendment to the Federal Food, Drug and Cosmetic Act, under ...
  114. [114]
    Supplement industry leaders advocate for health and nutrition policy
    Jun 26, 2025 · Supplement Leaders Lobby Congress. Industry executives met with legislators to discuss key issues like HSA/FSA access for supplements, mandatory ...
  115. [115]
    Dietary supplements: Underregulated, unknown and maybe unsafe
    May 11, 2022 · The agency already has the authority to regulate dietary supplements, but it is simply unaware of many of the 50,000–80,000 on the market.Missing: debates multivitamin
  116. [116]
    What Should Dietary Supplement Oversight Look Like in the US?
    May 1, 2022 · Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform.<|separator|>
  117. [117]
    [PDF] Regulatory Issues with U.S. Dietary Supplements
    Feb 1, 2013 · The. DSHEA was passed only after extensive lobbying by certain politicians and by the industry owners. The DSSA could have been enacted if ...Missing: multivitamin | Show results with:multivitamin
  118. [118]
    The Evolution of Science and Regulation of Dietary Supplements
    The science surrounding dietary supplements has evolved substantially over the last few decades since their formal regulation in 1994.Perspectives · Dietary Supplement Science... · Appendix A. Supplementary...<|separator|>
  119. [119]
    “Common questions and misconceptions about dietary supplements ...
    Jul 15, 2025 · However, industry-funded research is often criticized and sometimes questioned due to the potential risk of bias in research reporting and/or ...Missing: policy | Show results with:policy
  120. [120]
    Pfizer Consumer Healthcare Responds to PHS II Findings with ...
    Oct 17, 2012 · Article · Pfizer Consumer Healthcare Responds to PHS II Findings with Statement and Centrum® Silver® Multivitamin B-roll and Photo Assets.
  121. [121]
    Pfizer to remove "breast health" and "colon health" claims from ...
    Jul 6, 2012 · The CSPI called for the removal of those claims because in its view, they implied taking vitamins would protect against breast and colon cancer.
  122. [122]
    Vitamin D acceptance delayed by Big Pharma following the ...
    Jul 2, 2024 · Big Pharma and its allies in the U.S. and perhaps also in Europe are opposing major recommendations for increases in vitamin D intakes and ...
  123. [123]
    [PDF] Creating Balance: Problems Within DSHEA and Suggestions for ...
    In creating dietary supplement regulation Congress is influ- enced by the lobbying efforts of two primary entities, FDA and the dietary supplement industry." In ...Missing: multivitamin | Show results with:multivitamin